Literature DB >> 21184044

[Interventional lung assist membrane ventilator. Successful use despite heparin-induced thrombocytopenia type II].

J Lange1, D Knüttgen, E Stoelben, U Bauerfeind, F Wappler, S G Sakka.   

Abstract

Pumpless extracorporeal carbon dioxide elimination using the interventional lung assist (iLA) membrane ventilator is a modern concept for the treatment of hypercapnia due to respiratory failure which cannot be sufficiently treated by conventional strategies. Heparin-induced thrombocytopenia type II (HIT II) is considered to be an absolute contraindication for placement of an iLA because of the system's heparin-coated diffusion membrane. The example demonstrates that iLA therapy can be continued despite occurrence of a HIT II in terms of an "off label use". In the case described, postoperative therapy using the iLA membrane ventilator was installed in a 69-year-old patient with severe ARDS after elective lung resection. Despite a confirmed HIT II detected in the course of iLA, this therapy was continued after changing systemic anticoagulation to argatroban. The platelet count increased again and the patient could be successfully weaned from the iLA membrane and finally transferred to a rehabilitation centre.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21184044     DOI: 10.1007/s00101-010-1801-z

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  15 in total

1.  Heparin-coated catheters and heparin-induced thrombocytopenia.

Authors:  J Laster; D Silver
Journal:  J Vasc Surg       Date:  1988-05       Impact factor: 4.268

2.  [Status asthmaticus. Role of extracorporeal lung assist procedures].

Authors:  L Aniset; A Kalenka
Journal:  Anaesthesist       Date:  2010-04       Impact factor: 1.041

3.  An expanded definition of the adult respiratory distress syndrome.

Authors:  J F Murray; M A Matthay; J M Luce; M R Flick
Journal:  Am Rev Respir Dis       Date:  1988-09

4.  Percutaneous extracorporeal arteriovenous CO2 removal for severe respiratory failure.

Authors:  J B Zwischenberger; S A Conrad; S K Alpard; L R Grier; A Bidani
Journal:  Ann Thorac Surg       Date:  1999-07       Impact factor: 4.330

5.  Pumpless extracorporeal lung assist - experience with the first 20 cases.

Authors:  A Liebold; C M Reng; A Philipp; M Pfeifer; D E Birnbaum
Journal:  Eur J Cardiothorac Surg       Date:  2000-05       Impact factor: 4.191

6.  Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodies.

Authors:  J L Laster; W K Nichols; D Silver
Journal:  Arch Intern Med       Date:  1989-10

7.  Extrapulmonary ventilation for unresponsive severe acute respiratory distress syndrome after pulmonary resection.

Authors:  Manuela Iglesias; Elisabeth Martinez; Joan Ramon Badia; Paolo Macchiarini
Journal:  Ann Thorac Surg       Date:  2008-01       Impact factor: 4.330

8.  Bronchial fistulae in ARDS patients: management with an extracorporeal lung assist device.

Authors:  M Hommel; M Deja; V von Dossow; K Diemel; C Heidenhain; C Spies; S Weber-Carstens
Journal:  Eur Respir J       Date:  2008-12       Impact factor: 16.671

9.  [Pumpless extracorporeal lung assist using arterio-venous shunt in severe ARDS. Experience with 30 cases].

Authors:  T Bein; C Prasser; A Philipp; T Müller; F Weber; H J Schlitt; F-X Schmid; K Taeger; D Birnbaum
Journal:  Anaesthesist       Date:  2004-09       Impact factor: 1.041

10.  Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy.

Authors:  T Müller; M Lubnow; A Philipp; T Bein; A Jeron; A Luchner; L Rupprecht; M Reng; J Langgartner; C E Wrede; M Zimmermann; D Birnbaum; C Schmid; G A J Riegger; M Pfeifer
Journal:  Eur Respir J       Date:  2008-11-14       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.